Study of Anti-Tumor Activing of IL-1.BETA. ( OCT-43 ) Nude Mouse Transplantabile Human Malignant Melanoma ( SK-14 Strain ) and Renal Cancer ( RCC-1 Strain ).

Skin Cancer
doi 10.5227/skincancer.6.345
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Japanese Skin Cancer Society

Related search

Antitumor Effect of MY-1 for Nude Mouse Transplantability Human Malignant Melanoma.

Skin Cancer
1990English

Late Phase II Study of Recombinant IL-1.BETA. Derivative(OCT-43) in Patients With Mycosis Fungoides.

Skin Cancer
1995English

Functional Role of Interleukin 1 Beta (IL-1 Beta) in IL-1 Beta- Converting Enzyme-Mediated Apoptosis

Journal of Experimental Medicine
MedicineAllergyImmunology
1996English

STRAIN DEPENDENCY OF TRANSFORMING GROWTH FACTOR-BETA 1 (TGF-betal) REQUIREMENT FOR PREIMPLANTATION MOUSE DEVELOPMENT. † 352

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Rapid and Specific Conversion of Precursor Interleukin 1 Beta (IL-1 Beta) to an Active IL-1 Species by Human Mast Cell Chymase

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Table 1: Strain RIT389 Genome Statistic and Strain Information.

English

Safety and Tumor Responses With Lambrolizumab (Anti–PD-1) in Melanoma

New England Journal of Medicine
Medicine
2013English

Caveolin-1 Tumor-Promoting Role in Human Melanoma

International Journal of Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy